Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants

Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants

Background: Patients with non-valvular atrial fibrillation (NVAF) need prophylactically antithrombotic therapies to reduce the risk of stroke. We hypothesized that the prognostic benefits of prophylactic antithrombotic therapies outweighed the bleeding risk among very elderly (≥85 years old) patient...

Full description

Bibliographic Details
Main Authors: U Fan O, Tou Kun Chong, Yulin Wei, Bishow Paudel, Michael C. Giudici, Chi Wa Wong, Wai Kit Lei, Jian Chen, Wei Wu, Kan Liu
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Non-valvular atrial fibrillation
Very elderly
Non-vitamin K antagonist oral anticoagulants
Bleeding
Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906722000586

Internet

http://www.sciencedirect.com/science/article/pii/S2352906722000586

Similar Items